↓ Skip to main content

Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004)

Overview of attention for article published in International Journal of Radiation Oncology, Biology, Physics, October 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
7 news outlets
blogs
1 blog
policy
1 policy source
twitter
19 X users

Citations

dimensions_citation
116 Dimensions

Readers on

mendeley
149 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004)
Published in
International Journal of Radiation Oncology, Biology, Physics, October 2013
DOI 10.1016/j.ijrobp.2013.06.2044
Pubmed ID
Authors

Robert A. Huddart, Emma Hall, Syed A. Hussain, Peter Jenkins, Christine Rawlings, Jean Tremlett, Malcolm Crundwell, Fawzi A. Adab, Denise Sheehan, Isabel Syndikus, Carey Hendron, Rebecca Lewis, Rachel Waters, Nicholas D. James

Abstract

To test whether reducing radiation dose to uninvolved bladder while maintaining dose to the tumor would reduce side effects without impairing local control in the treatment of muscle-invasive bladder cancer.

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Unknown 147 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 23 15%
Other 22 15%
Student > Postgraduate 17 11%
Student > Doctoral Student 17 11%
Student > Master 12 8%
Other 33 22%
Unknown 25 17%
Readers by discipline Count As %
Medicine and Dentistry 91 61%
Nursing and Health Professions 5 3%
Physics and Astronomy 3 2%
Pharmacology, Toxicology and Pharmaceutical Science 2 1%
Agricultural and Biological Sciences 1 <1%
Other 9 6%
Unknown 38 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 66. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 February 2021.
All research outputs
#658,439
of 25,655,374 outputs
Outputs from International Journal of Radiation Oncology, Biology, Physics
#184
of 11,142 outputs
Outputs of similar age
#5,429
of 220,505 outputs
Outputs of similar age from International Journal of Radiation Oncology, Biology, Physics
#1
of 113 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,142 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 220,505 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 113 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.